Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get Microdata
Reference ID
LBR_2015_HRBFIE-BL_v01_M
Producer(s)
Kenneth Leonard (University of Maryland), Luke Bawo, Rianna Mohammed-Roberts
Collection(s)
Metadata
Created on
Jan 13, 2020
Last modified
Jan 13, 2020
Page views
212599
Downloads
213
Q106: M. Other (specify) (q106msp)
Data file: p_v_3
Overview
Valid:
41
Invalid:
0
Type:
Discrete
Start:
456
End:
505
Width:
50
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACT | 1 |
2.4%
|
|
| Artesunate | 1 |
2.4%
|
|
| B-Complex | 1 |
2.4%
|
|
| D50 | 1 |
2.4%
|
|
| D50% | 1 |
2.4%
|
|
| D50%, DEWORM | 1 |
2.4%
|
|
| D50%, M-VIT, | 1 |
2.4%
|
|
| DEWORM | 1 |
2.4%
|
|
| DEWORM THE CHILD, GIVE FEFA & M-VIT | 1 |
2.4%
|
|
| DEWORM, NYSTATIN, B-2 | 1 |
2.4%
|
|
| Deworm | 1 |
2.4%
|
|
| Dr Bco, Blood tonic | 1 |
2.4%
|
|
| FEFA | 1 |
2.4%
|
|
| FEFA, M-VIT | 1 |
2.4%
|
|
| FEFA, PCM | 1 |
2.4%
|
|
| FESO4 | 1 |
2.4%
|
|
| FLAGY SYRUP | 1 |
2.4%
|
|
| FLAGY, AMOX, PCM, FEFA, M-VIT | 1 |
2.4%
|
|
| FOLIC,FERROUS | 1 |
2.4%
|
|
| Flaggy IV D500% | 1 |
2.4%
|
|
| Flagy, M/Vit,Abendizoi | 1 |
2.4%
|
|
| Folic Acid, Iron | 1 |
2.4%
|
|
| Iron tablet | 1 |
2.4%
|
|
| M-VIT | 1 |
2.4%
|
|
| M-VIT, FEFA | 1 |
2.4%
|
|
| M-VIT, FESO4 | 1 |
2.4%
|
|
| M-VIT, FOLIC ACID | 1 |
2.4%
|
|
| M-VIT, IF TEST SHOW POSITIVE FOR MALARIA GIVE ACT | 1 |
2.4%
|
|
| M/VIT, Ferrous | 1 |
2.4%
|
|
| M/Vitimi (M/Vitamin), Vimox (Vermox) | 1 |
2.4%
|
|
| METRO | 1 |
2.4%
|
|
| METRO, FEFA | 1 |
2.4%
|
|
| METRONIDAZOLE | 1 |
2.4%
|
|
| NYSTATIN PO. | 1 |
2.4%
|
|
| Put uP m/s D50% | 1 |
2.4%
|
|
| SEPTRIN | 1 |
2.4%
|
|
| SEPTRIN, M-VIT | 1 |
2.4%
|
|
| SEPTRIN, VERMOX, M-VIT | 1 |
2.4%
|
|
| Vermox, Fefa, M/Vit | 1 |
2.4%
|
|
| Vitamins | 1 |
2.4%
|
|
| WORM MEDICATIONS,FERROUS | 1 |
2.4%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.